STOCK TITAN

Penumbra Inc SEC Filings

PEN NYSE

Welcome to our dedicated page for Penumbra SEC filings (Ticker: PEN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Locating R&D spend for Penumbra’s Lightning Flash thrombectomy platform or tracking how stroke-care sales trend across 100+ countries can feel like navigating a catheter through tight anatomy. The company’s disclosures span hundreds of pages, and the detail investors need—product line revenue, pipeline milestones, or 510(k) updates—often hides deep inside footnotes.

Stock Titan turns that complexity into clarity. Our AI reads every Penumbra annual report 10-K simplified, each Penumbra quarterly earnings report 10-Q filing, and even the swift Penumbra 8-K material events explained, then extracts what matters. Need Penumbra insider trading Form 4 transactions before market open? We send alerts the moment a Penumbra Form 4 insider transactions real-time hits EDGAR. Wonder how directors are paid? The Penumbra proxy statement executive compensation is summarized in plain English. For fast answers, just ask “understanding Penumbra SEC documents with AI” or “Penumbra earnings report filing analysis” and jump straight to the insight.

What you’ll uncover here:

  • Device segment revenue shifts across neurovascular and peripheral vascular markets
  • Regulatory milestones that could accelerate sales growth
  • Penumbra executive stock transactions Form 4 patterns around product launches

Whether you’re screening for valuation catalysts or monitoring compliance risk, this page delivers every filing—10-K, 10-Q, 8-K, S-8, and more—with real-time updates and AI-powered summaries that explain filing meanings in simple terms. No more PDF scavenging; the critical data on Penumbra SEC filings explained simply is already parsed and ready for decision-making.

Rhea-AI Summary

Penumbra Inc. director Harpreet Grewal reported a small insider sale of common stock. On January 6, 2026, Grewal sold 186 shares of Penumbra common stock at a price of $312.64 per share under a pre-arranged Rule 10b5-1 trading plan. After this transaction, Grewal directly beneficially owned 8,230 shares of Penumbra common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Penumbra Inc. director Thomas C. Wilder reported a small sale of company stock. On 01/02/2026, he sold 186 shares of Penumbra common stock at a price of $310.72 per share, coded as a sale transaction. Following this trade, he no longer holds shares directly but continues to beneficially own 4,506 shares indirectly through the Thomas and Catharine Wilder Family Trust dated March 31, 2006.

The filing notes that the sale was carried out under a pre-established Rule 10b5-1 trading plan, which is designed to allow insiders to sell shares according to predetermined instructions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Penumbra, Inc. insider Harpreet Grewal has filed a notice of proposed sale under Rule 144 for 186 shares of common stock, with an aggregate market value of 58,151.04. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE around January 6, 2026, and Penumbra has 39,162,177 shares of common stock outstanding.

The 186 shares to be sold were acquired as a stock award from Penumbra on December 31, 2025. Over the prior three months, the same seller disposed of 186 shares on November 4, 2025 for 42,329.88 and 100 shares on December 2, 2025 for 29,298.00. By signing the notice, the seller represents that they do not know of any material adverse, nonpublic information about Penumbra’s operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

A holder of PEN common stock has filed a notice to potentially sell shares under Rule 144. The filing covers the planned sale of 186 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, with an indicated aggregate market value of $57,793.92. The issuer had 39,162,177 shares outstanding at the time referenced. The shares to be sold were acquired as restricted stock from the issuer on 12/31/2025, with payment also dated 12/31/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Penumbra Inc's chief financial officer, Maggie Yuen, reported a tax-related share withholding tied to her equity compensation. On 12/15/2025, 565 shares of Penumbra common stock were withheld by the company at a price of $309.15 per share, identified with transaction code F for tax withholding.

After this transaction, Yuen beneficially owned 16,006 Penumbra shares, some of which remain subject to vesting. The total includes 15 shares purchased under Penumbra's Employee Stock Purchase Plan on November 19, 2025. The filing characterizes the withholding as satisfying tax obligations arising from the vesting of restricted stock units previously granted to her.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Penumbra’s chief accounting officer, Lambert Shiu, reported an insider transaction involving 300 shares of common stock on 12/15/2025. The 300 shares were withheld by the company to cover tax withholding obligations triggered by the vesting of restricted stock units previously granted to him.

After this transaction, Shiu beneficially owns 35,285 Penumbra common shares directly, with a portion of these shares still subject to vesting and including 20 shares purchased under the company’s Employee Stock Purchase Plan on November 19, 2025. He also indirectly owns 300 shares held in his spouse’s IRA.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Penumbra Inc. executive Johanna Roberts, EVP, General Counsel & Secretary, reported a tax-related share withholding tied to equity compensation. On 12/15/2025, 1,130 shares of Penumbra common stock were disposed of at $309.15 per share under transaction code F, which indicates shares withheld to satisfy tax obligations on vesting restricted stock units.

After this transaction, she beneficially owns 62,706 shares of Penumbra common stock, and a portion of these shares remains subject to vesting. No derivative securities transactions were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Penumbra Inc. director Arani Bose reported multiple open-market sales of Penumbra common stock on 12/11/2025, carried out under a pre-arranged Rule 10b5-1 trading plan. The transactions, all coded as sales, were executed in several tranches, including 2,030 shares at a weighted average price of $305.19, 4,946 shares at $306.6, and 3,523 shares at $311.47, with other trades priced in the general range of $305–$312 per share.

Following one of the reported transactions, the filing shows 258,462 shares of Penumbra common stock beneficially owned indirectly through Bose Family Holdings II, LLC, and a portion of these shares is subject to vesting. The filing emphasizes that several trades were executed in multiple lots within stated price ranges, with the weighted average prices reported and full trade details available upon request.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Penumbra Inc. executive vice president, general counsel and secretary reported a small stock sale under a pre-arranged trading plan. On 12/05/2025, the reporting person sold 300 shares of Penumbra common stock at a weighted average price of $300.13 per share under a Rule 10b5-1 trading plan, which allows preset trades to occur over time. After this transaction, the insider beneficially owned 63,836 shares of Penumbra common stock, a portion of which remains subject to vesting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Penumbra, Inc. reported insider trading activity by its EVP, General Counsel & Secretary, Johanna Roberts. On 12/01/2025, she executed several small open-market sales of Penumbra common stock under a pre-arranged Rule 10b5-1 trading plan. The reported weighted average sale prices ranged from about $292.09 to $298.02 per share across multiple trades. After these transactions, she beneficially owned 64,136 shares of Penumbra common stock, and a portion of these shares is subject to vesting. All sales were reported as directly owned shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Penumbra (PEN)?

The current stock price of Penumbra (PEN) is $313.43 as of January 14, 2026.

What is the market cap of Penumbra (PEN)?

The market cap of Penumbra (PEN) is approximately 11.8B.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Stock Data

11.79B
37.48M
3.66%
93.38%
4.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA